RELMADA THERAPEUTICS, INC. Annual Return On Equity in % from 2013 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Relmada Therapeutics, Inc. annual/quarterly Return On Equity history and growth rate from 2013 to 2023.
  • Relmada Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2022 was -78.5 %.
  • Relmada Therapeutics, Inc. annual Return On Equity for 2023 was -93.4 %, a 6.22% decline from 2022.
  • Relmada Therapeutics, Inc. annual Return On Equity for 2022 was -88 %, a 18% increase from 2021.
  • Relmada Therapeutics, Inc. annual Return On Equity for 2021 was -107 %, a 113% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -93.4 -5.47 -6.22% Jan 1, 2023 Dec 31, 2023
2022 -88 +19.3 +18% Jan 1, 2022 Dec 31, 2022
2021 -107 -57 -113% Jan 1, 2021 Dec 31, 2021
2020 -50.3 -4 -8.65% Jan 1, 2020 Dec 31, 2020
2019 -46.3 -681 -107% Jan 1, 2019 Dec 31, 2019
2018 635 +808 Jul 1, 2017 Jun 30, 2018
2017 -173 -146 -524% Jul 1, 2016 Jun 30, 2017
2016 -27.8 -1.75K -102% Jul 1, 2015 Jun 30, 2016
2015 1.72K Jul 1, 2014 Jun 30, 2015
2013 442 Jan 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.